Armstrong Shaw Associates Inc Gilead Sciences, Inc. Transaction History
Armstrong Shaw Associates Inc
- $94.5 Million
- Q3 2023
A detailed history of Armstrong Shaw Associates Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Armstrong Shaw Associates Inc holds 2,950 shares of GILD stock, worth $220,512. This represents 0.23% of its overall portfolio holdings.
Number of Shares
2,950
Previous 2,950
-0.0%
Holding current value
$220,512
Previous $227,000
2.64%
% of portfolio
0.23%
Previous 0.23%
Shares
7 transactions
Others Institutions Holding GILD
# of Institutions
1,876Shares Held
1.02BCall Options Held
12MPut Options Held
8.96M-
Black Rock Inc. New York, NY121MShares$9.02 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.62 Billion0.15% of portfolio
-
Capital World Investors Los Angeles, CA76.2MShares$5.7 Billion0.88% of portfolio
-
Capital Research Global Investors Los Angeles, CA60.4MShares$4.52 Billion0.94% of portfolio
-
State Street Corp Boston, MA59.3MShares$4.43 Billion0.18% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $93.7B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...